PDCD1 and lung carcinoma: The immune checkpoint analysis displayed seemingly contradictory results between expression level and prognosis; however, research has also shown that high expression of PD1 and PD-L1 is associated with favorable outcome in lung cancer of early-stage but an adverse outcome in late-stage [34].